&w=3840&q=100)
Smallcap stock soars 15% on heavy volumes on Monday; zooms 69% in 7 weeks
Camlin Fine Sciences share price today
Shares Camlin Fine Sciences (CFSL) hit a multi-year high of ₹216.20, surging 15 per cent on the BSE in Monday's intra-day trade amid heavy volumes after the company reported a strong operational performance for the March 2025 quarter (Q4FY25).
The smallcap stock was trading close to its record high of ₹225.47 touched on June 19, 2021. In the past seven weeks, the market price of specialty chemicals has appreciated by 69 per cent from a level of ₹128.10 on April 7, 2025.
At 11:43 AM; CFSL quoted 14 per cent higher at ₹214, as compared to 0.5 per cent rise in the BSE Sensex. The average trading volumes at the counter jumped over three-fold. A combined 8.36 million equity shares representing 4.4 per cent of total equity of the company changed hands on the NSE and BSE.
Strong operational performance in Q4
In the March 2025 quarter (Q4FY25), the company reported strong 88.7 per cent year-on-year (YoY) growth in earnings before interest, taxes, depreciation and amortisation (EBITDA) at ₹59.41 crore, against ₹31.48 crore in Q4FY24. Reported EBITDA margins expanded to 13.6 per cent from 8.4 per cent in a year ago quarter. Revenue from operations grew 16.1 per cent YoY to ₹437.46 crore from ₹376.65 crore. Profit after tax (PAT) increased 16.9 per cent YoY at ₹22.74 crore.
CFSL has a significant global presence, with nine manufacturing facilities spread across Asia, Europe, South America and Central America. The company has strong regional sales teams that cater to the requirements of their respective regions.
At the consolidated level, CFSL derives around 85 per cent of its revenue from exports and from overseas subsidiaries, with over 100 products sold in around 80 countries. The company caters to diverse end user industries such as food, feed, animal and pet nutrition, flavours and fragrances, pharma, agrochemicals, and petrochemicals among others. This helps the company avoid dependence on any single industry and provides potential for expansion.
Moreover, the vertically integrated operations and the regional sales team enables CFSL to customise product offerings as per the client's requirements, which has helped it develop long-standing relations with its customers.
Way Forward
Specialty Ingredients - Maintaining market leadership for Antioxidants. The company said it increasingly focusing on high margin blends and additives. These formulations are specifically tailored to meet the diverse needs of the industry. Widen portfolio to provide a comprehensive solution for the food, pet food, biodiesel, livestock and aquaculture industries.
Performance Chemicals - Aim to expand Diphenol chain, specifically focusing on expanding downstream products. The company is planning the introduction of new products like CME, Chloranil, and Napthol etc. It is planning to increase manufacturing capacity of existing products through debottlenecking. The company aims to give a major impetus to the 'Make in India' initiative by launching exciting products.
Aroma Ingredients - The company plans to introduce specialized and customized products within the vanillin range, catering to diverse application needs. The management is actively pursuing an expansion in the aroma industry. The production of Ethyl Vanillin and vanillin ex-clove (natural vanillin) completes a comprehensive range of Vanillin offerings for the market. The company aims to achieve optimum capacity utilization in coming years.
About Camlin Fine Sciences
CFSL is inter-alia engaged in the business of diverse high-quality innovative antioxidants and shelf-life extensions, aroma ingredients, performance chemical products and related solutions for food, animal nutrition, pet food, pharmaceutical and petrochemical industries globally.
The company is a leading manufacturer of Speciality Chemicals that can be broadly categorised into Shelf-Life Solutions, Performance Chemicals, Aroma Ingredients and Health & Wellness. These products are used in varied industries such as human food, animal feed, pet food, agrochemicals, petrochemicals, pharmaceuticals, nutraceuticals, flavours and fragrances and health care.
Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles
Time of India
17 minutes ago
- Time of India
HeidelbergCement India's profit up 4.7% to ₹50.45 crore in Q4 FY25
NEW DELHI: HeidelbergCement India Ltd has reported a 4.75 per cent increase in net profit to Rs 50.45 crore in the March quarter of FY25. The company had reported a net profit of Rs 48.16 crore in the January-March quarter a year ago, HeidelbergCement India said in a regulatory filing on Wednesday. Its revenue from operations was 2.66 per cent to Rs 612.46 crore in the March quarter. It was at Rs 596.55 crore a year ago. The company recorded a rise in revenue, which was "primarily due to 2 per cent increase in sales volume and 1 per cent increase in prices", the company said in its earnings statement. Total expenses of HeidelbergCement India in the March quarter were at Rs 544.11 crore, up 1.75 per cent. Its total income was at Rs 623.67 crore in the March quarter, up 2.18 per cent. HeidelbergCement India is a subsidiary of Heidelberg Materials , a German multinational building materials company. For the financial year ended on Mar 31, 2025, HeidelbergCement's net profit was down 36.4 per cent to Rs 106.75 crore. Its consolidated income for the fiscal was also down 9.33 per cent to Rs 2,194.35 crore. HeidelbergCement's sales volume in FY25 was down 6.1 per cent to 4,515 kilo tonne. Shares of HeidelbergCement India Ltd on Thursday were trading at Rs 199.45 on the BSE, down 0.72 per cent from the previous close.
Time of India
17 minutes ago
- Time of India
Asian Granito India posts ₹16.41 crore profit in Q4 FY25
NEW DELHI: Asian Granito India (AGIL) has reported net consolidated profit after tax of ₹16.41 crore during the quarter ended March 31, 2025. It had registered loss after tax ₹5.41 crore it registered in the corresponding quarter of the previous fiscal, the company said in a BSE filing. The company's net consolidated total income stood at ₹478.49 crore in Q4 FY25, a growth of 11.78 per cent from ₹428.06 crore it recorded in the similar quarter last year. Kamlesh Patel , chairman and managing director of the company said, "Despite the current volatility in the market and economy, the company has closed Q4 and FY25 on a good note, achieving better operational and financial performance, indicating improvement. We are steadfast on our commitment to achieve total revenue of ₹6,000 crore in next 4-6 years." The board of directors considered and approved an investment by making subscription of 51% of total share capital of the proposed post which it will become subsidiary of the company. In Q4 FY25, net sales of the company was reported at ₹471.62 crore, exports was at ₹86 crore. Exports during FY25 were at ₹291 crore and comprised 19% of revenue. In Q3 FY25, AGIL had completed the conversion of all outstanding warrants into equity shares. In October 2024, the company allotted 77.82 lakh and 47.14 lakh equity shares, respectively, upon warrant conversion. Subsequently, in November 2024, an additional 78.03 lakh shares were issued at ₹48.15 per share (including a ₹38.15 premium), raising ₹28.18 crore from promoter group investors. These conversions increased company's issued, subscribed, and paid-up equity share capital to ₹147.04 crore, comprising 14.70 crore fully paid-up shares of ₹10 each. As a result, the promoter group's holding rose from 29.02% in September 2024 to 33.52% as on March 2025.
Time of India
17 minutes ago
- Time of India
Puravankara's net loss widens to ₹88 crore in Q4 FY25
NEW DELHI: Puravankara has reported net consolidated loss after tax of ₹88 crore during the quarter ended March 31, 2025. It had registered loss after tax ₹6.71 crore it registered in the corresponding quarter of the previous fiscal, the company said in a BSE filing. The company's net consolidated total income stood at ₹563.70 crore in Q4 FY25, a dip of 40.47 per cent from ₹946.84 crore it recorded in the similar quarter last year. Ashish Puravankara , managing director of the company said, "FY25 saw record sustenance sales, and our western India investments are now poised to come to market. We are also actively pursuing several major redevelopment projects. With over 13.5 million sq. ft. in the pipeline group-wide, and key approvals in place, we are optimistic about delivering long-term value to all stakeholders." During the quarter ended March 31, 2025, the company had acquired an additional stake of 39.54% in an existing associate entity - Sobha Puravankara Aviation (SPAPL) from another shareholders for a consideration of ₹0.04 crore. Pursuant to the said acquisition, the company holds 89.49% shareholding and SPAPL has become a subsidiary of the company. In Q4 FY25, pre-sales stood at ₹1,282 crore, sales volume of 1.42 million sq ft and collections of ₹946 crore. During the quarter ended March 31, 2025, a wholly-owned subsidiary of the company had acquired 51% voting right and control thereon in NBD Office Parks LLP for a consideration of ₹2.96 crore thereby NBD Office Parks LLP has become a subsidiary of the Group. For FY25, the company achieved robust pre-sales of ₹5,006 crore, with a sales volume of 5.67 million sq ft and a 10% year-on-year increase in sales realisation to ₹8,830 per sq ft. Collections for the year stood at ₹3,937 crore, reflecting a 9% growth over the previous year. Total revenue came in at ₹2,093 crore, while operating cash inflows grew by 10% year-on-year to ₹4,342 crore. During the quarter ended March 31, 2025, PURVACOM, a partnership entity in which the company held 99.99% stake has been dissolved. The company has announced a joint venture with KVN Property Holdings LLP to develop a 24.59-acre land parcel in North Bengaluru 's KIADB Hardware Park. The project has an estimated gross development value (GDV) of over ₹3,300 crore and a saleable area of 3.48 million sq ft. During FY25, the company expanded its presence in Western India by acquiring four projects, including redevelopment projects, across Lokhandwala, Pali Hill, Breach Candy, and Thane having a combined GDV potential of over ₹9,500 crore. The company hopes to derive 40% of future revenues from Mumbai and Pune. In March 2025, the company launched Purva Panorama project in Thane, with a total development potential of three million sq ft and an estimated GDV of ₹4,000 crore. Puravankara's net debt stood at ₹2,949 crore, and the net debt-to-equity ratio stood at 1.70 as on March 31, 2025. The weighted average cost of debt stood at 11.85% as on March 31, 2025.
